UA103309C2 - Pharmaceutical composition for oral administration comprises chondroitin sulfate salt and glycosamine sulfate salt, ibuprofen - Google Patents
Pharmaceutical composition for oral administration comprises chondroitin sulfate salt and glycosamine sulfate salt, ibuprofenInfo
- Publication number
- UA103309C2 UA103309C2 UAA201007842A UAA201007842A UA103309C2 UA 103309 C2 UA103309 C2 UA 103309C2 UA A201007842 A UAA201007842 A UA A201007842A UA A201007842 A UAA201007842 A UA A201007842A UA 103309 C2 UA103309 C2 UA 103309C2
- Authority
- UA
- Ukraine
- Prior art keywords
- sulfate salt
- ibuprofen
- pharmaceutical composition
- oral administration
- chondroitin sulfate
- Prior art date
Links
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical class FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 title abstract 3
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001680 ibuprofen Drugs 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- -1 glycosamine sulfate salt Chemical class 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 4
- 230000003412 degenerative effect Effects 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000004615 ingredient Substances 0.000 abstract 2
- 201000008482 osteoarthritis Diseases 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- MTDHILKWIRSIHB-UHFFFAOYSA-N (5-azaniumyl-3,4,6-trihydroxyoxan-2-yl)methyl sulfate Chemical class NC1C(O)OC(COS(O)(=O)=O)C(O)C1O MTDHILKWIRSIHB-UHFFFAOYSA-N 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000003011 chondroprotective effect Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000005713 exacerbation Effects 0.000 abstract 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to the field of medicine and, more particularly, to drugs for internal use to treat a pain syndrome during a pain exacerbation phase in primary osteoarthrosis and secondary osteoarthrosis and other degenerative dystrophic diseases of extremity joints and intervertebral disks. The pharmaceutical composition for oral administration comprises chondroitin sulfate salt and glycosamine sulfate salt, ibuprofen as a nonsteroidal anti-inflammatory drug, and auxiliary substances wherein the ingredients are comprised in the following ingredient ratio (% w/w): Chondroitin sulfate salt 20 to 30 Glucosamine sulfate salt 30 to 36 Ibuprofen 10 to 15 and auxiliary substances Q, S. The present invention provides a pharmaceutical composition which ensures a chondroprotective, anti-inflammatory, and analgetic effect, an effective treatment of degenerative dystrophic diseases of extremity joints and intervertebral disks, a convenience of using the medicine, decrease in side effect risks, and the provision of an alternative medicament.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201007842A UA103309C2 (en) | 2007-11-23 | 2008-11-21 | Pharmaceutical composition for oral administration comprises chondroitin sulfate salt and glycosamine sulfate salt, ibuprofen |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2007012960 | 2007-11-23 | ||
| UAA201007842A UA103309C2 (en) | 2007-11-23 | 2008-11-21 | Pharmaceutical composition for oral administration comprises chondroitin sulfate salt and glycosamine sulfate salt, ibuprofen |
| PCT/EP2008/009897 WO2009065604A2 (en) | 2007-11-23 | 2008-11-21 | Pharmaceutical composition comprising glucosamine sulfate, chondroitine sulfate and ibuprofene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA103309C2 true UA103309C2 (en) | 2013-10-10 |
Family
ID=52283150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201007842A UA103309C2 (en) | 2007-11-23 | 2008-11-21 | Pharmaceutical composition for oral administration comprises chondroitin sulfate salt and glycosamine sulfate salt, ibuprofen |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA103309C2 (en) |
-
2008
- 2008-11-21 UA UAA201007842A patent/UA103309C2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2470016C2 (en) | Bipirazole derivative | |
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| WO2007112274A3 (en) | Formulations of low dose non-steroidal anti-inflammatory drugs and beta-cyclodextrin | |
| SI2529622T1 (en) | Bruton tyrosine kinase inhibitors | |
| Lee et al. | Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial | |
| IL196425A0 (en) | Pharmaceutical compositions containing ibuprofen and famotidine | |
| WO2007012019A3 (en) | Medicaments containing famotidine and ibuprofen and administration of same | |
| WO2006069293A3 (en) | Composition comprising n-acetylcysteine and further pain or anti- inflamm medications | |
| WO2005035485A3 (en) | Analgesic compounds, their synthesis and pharmaceutical compositions containing them | |
| BR112013010829B8 (en) | Intravenous pharmaceutical composition to provide relief from pain and/or inflammation | |
| US20190374491A1 (en) | Topical preparation for pain relief | |
| CA2570474A1 (en) | A combination composition comprising paracetamol and ibuprofen | |
| WO2004100893A3 (en) | Methods for treatment of inflammatory diseases using ct-3 or analogs thereof | |
| AU2009304002B9 (en) | A medicinal product and treatment | |
| WO2008008882A3 (en) | Glucocorticoid receptor modulator and methods of use | |
| Rose et al. | Comparison of lornoxicam and rofecoxib in patients with activated osteoarthritis (COLOR Study) | |
| JP2016505050A5 (en) | ||
| CA2476939A1 (en) | Pharmaceutical combinations of cox-2 inhibitors and opiates | |
| ZA202101688B (en) | Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain | |
| MX384760B (en) | A synergic pharmaceutical combination of the active etianomer s-ketorolaco and gabapentin for the treatment of neuropathic pain | |
| WO2009065604A3 (en) | Pharmaceutical composition comprising glucosamine sulfate, chondroitine sulfate and ibuprofene | |
| UA103309C2 (en) | Pharmaceutical composition for oral administration comprises chondroitin sulfate salt and glycosamine sulfate salt, ibuprofen | |
| UA93365C2 (en) | Injectable preparations of diclofenic and its pharmaceutically acceptable salts, and processes for the preparation thereof | |
| WO2020036478A3 (en) | Synergistic pharmaceutical composition comprising aceclofenac and betamethasone for the treatment of pain in localised forms of rheumatic illnesses | |
| WO2008000744A3 (en) | 2-0'-methyladen0sine derivatives and their use as agonists or antagonists of an adenosine receptor |